Cargando…
Nivolumab-induced myocardial necrosis in a patient with lung cancer: A case report
A 74-year-old man with lung adenocarcinoma recurrence was admitted to our hospital because of dyspnea 7 days after receiving initial immunotherapy with nivolumab. Electrocardiography revealed ST-segment elevation in V1-6 and echocardiography showed a markedly reduced left ventricular ejection fracti...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476808/ https://www.ncbi.nlm.nih.gov/pubmed/31024792 http://dx.doi.org/10.1016/j.rmcr.2019.100839 |
_version_ | 1783412935233634304 |
---|---|
author | Sakai, Takashi Yahagi, Kazuyuki Hoshino, Tatsuhiro Yokota, Toshiya Tanabe, Kengo Mori, Masaya Ikeda, Shingo |
author_facet | Sakai, Takashi Yahagi, Kazuyuki Hoshino, Tatsuhiro Yokota, Toshiya Tanabe, Kengo Mori, Masaya Ikeda, Shingo |
author_sort | Sakai, Takashi |
collection | PubMed |
description | A 74-year-old man with lung adenocarcinoma recurrence was admitted to our hospital because of dyspnea 7 days after receiving initial immunotherapy with nivolumab. Electrocardiography revealed ST-segment elevation in V1-6 and echocardiography showed a markedly reduced left ventricular ejection fraction of 9% and akinesis of the anteroseptal wall and apex. He died from acute heart failure 3 days after admission. Microscopically, multiple small foci of myocardial necrosis with few inflammatory cells were scattered in both ventricles. Obstruction of the coronary artery was not identified. We believed that the cause of death was acute heart failure possibly due to nivolumab-induced myocardial necrosis. |
format | Online Article Text |
id | pubmed-6476808 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-64768082019-04-25 Nivolumab-induced myocardial necrosis in a patient with lung cancer: A case report Sakai, Takashi Yahagi, Kazuyuki Hoshino, Tatsuhiro Yokota, Toshiya Tanabe, Kengo Mori, Masaya Ikeda, Shingo Respir Med Case Rep Article A 74-year-old man with lung adenocarcinoma recurrence was admitted to our hospital because of dyspnea 7 days after receiving initial immunotherapy with nivolumab. Electrocardiography revealed ST-segment elevation in V1-6 and echocardiography showed a markedly reduced left ventricular ejection fraction of 9% and akinesis of the anteroseptal wall and apex. He died from acute heart failure 3 days after admission. Microscopically, multiple small foci of myocardial necrosis with few inflammatory cells were scattered in both ventricles. Obstruction of the coronary artery was not identified. We believed that the cause of death was acute heart failure possibly due to nivolumab-induced myocardial necrosis. Elsevier 2019-04-15 /pmc/articles/PMC6476808/ /pubmed/31024792 http://dx.doi.org/10.1016/j.rmcr.2019.100839 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Sakai, Takashi Yahagi, Kazuyuki Hoshino, Tatsuhiro Yokota, Toshiya Tanabe, Kengo Mori, Masaya Ikeda, Shingo Nivolumab-induced myocardial necrosis in a patient with lung cancer: A case report |
title | Nivolumab-induced myocardial necrosis in a patient with lung cancer: A case report |
title_full | Nivolumab-induced myocardial necrosis in a patient with lung cancer: A case report |
title_fullStr | Nivolumab-induced myocardial necrosis in a patient with lung cancer: A case report |
title_full_unstemmed | Nivolumab-induced myocardial necrosis in a patient with lung cancer: A case report |
title_short | Nivolumab-induced myocardial necrosis in a patient with lung cancer: A case report |
title_sort | nivolumab-induced myocardial necrosis in a patient with lung cancer: a case report |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476808/ https://www.ncbi.nlm.nih.gov/pubmed/31024792 http://dx.doi.org/10.1016/j.rmcr.2019.100839 |
work_keys_str_mv | AT sakaitakashi nivolumabinducedmyocardialnecrosisinapatientwithlungcanceracasereport AT yahagikazuyuki nivolumabinducedmyocardialnecrosisinapatientwithlungcanceracasereport AT hoshinotatsuhiro nivolumabinducedmyocardialnecrosisinapatientwithlungcanceracasereport AT yokotatoshiya nivolumabinducedmyocardialnecrosisinapatientwithlungcanceracasereport AT tanabekengo nivolumabinducedmyocardialnecrosisinapatientwithlungcanceracasereport AT morimasaya nivolumabinducedmyocardialnecrosisinapatientwithlungcanceracasereport AT ikedashingo nivolumabinducedmyocardialnecrosisinapatientwithlungcanceracasereport |